Overview

Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Evaluation of safety and efficacy of a treatment associating Pegylated Liposomal Doxorubicin + Docetaxel in patients with metastatic breast cancer
Phase:
Phase 2
Details
Lead Sponsor:
ARCAGY/ GINECO GROUP
Treatments:
Docetaxel
Doxorubicin
Liposomal doxorubicin